WallStSmart

Verra Mobility Corp (VRRM)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Verra Mobility Corp generates 278% more annual revenue ($979.08M vs $258.90M). VRRM leads profitability with a 14.0% profit margin vs -15.5%. VRRM earns a higher WallStSmart Score of 63/100 (C+).

VRRM

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 8.0Value: 7.7Quality: 5.3
Piotroski: 3/9Altman Z: 1.17

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

VRRMUndervalued (+39.1%)

Margin of Safety

+39.1%

Fair Value

$30.49

Current Price

$14.87

$15.62 discount

UndervaluedFair: $30.49Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

VRRM5 strengths · Avg: 8.4/10
Return on EquityProfitability
49.0%10/10

Every $100 of equity generates 49 in profit

P/E RatioValuation
17.5x8/10

Attractively priced relative to earnings

Operating MarginProfitability
20.3%8/10

Strong operational efficiency at 20.3%

Revenue GrowthGrowth
16.4%8/10

16.4% revenue growth

EPS GrowthGrowth
38.1%8/10

Earnings expanding 38.1% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

VRRM2 concerns · Avg: 2.5/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.172/10

Distress zone — elevated risk

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : VRRM

The strongest argument for VRRM centers on Return on Equity, P/E Ratio, Operating Margin. Revenue growth of 16.4% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : VRRM

The primary concerns for VRRM are Piotroski F-Score, Altman Z-Score.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

VRRM profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

VRRM scores higher overall (63/100 vs 41/100) and 16.4% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Verra Mobility Corp

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Verra Mobility Corporation provides smart mobility technology solutions and services in the United States, Canada, and Europe. The company is headquartered in Mesa, Arizona.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?